Chronic hypersensitivity for inflammatory nociceptor sensitization mediated by the ε isozyme of protein kinase C

KO Aley, RO Messing, D Mochly-Rosen… - Journal of …, 2000 - Soc Neuroscience
KO Aley, RO Messing, D Mochly-Rosen, JD Levine
Journal of Neuroscience, 2000Soc Neuroscience
We have identified a mechanism, mediated by the ε isozyme of protein kinase C (PKCε) in
peripheral neurons, which may have a role in chronic inflammatory pain. Acute
inflammation, produced by carrageenan injection in the rat hindpaw, produced mechanical
hyperalgesia that resolved by 72 hr. However, for up to 3 weeks after carrageenan, injection
of the inflammatory mediators prostaglandin E2 or 5-hydroxytryptamine or of an adenosine
A2agonist into the same site induced a markedly prolonged hyperalgesia (> 24 hr compared …
We have identified a mechanism, mediated by the ε isozyme of protein kinase C (PKCε) in peripheral neurons, which may have a role in chronic inflammatory pain. Acute inflammation, produced by carrageenan injection in the rat hindpaw, produced mechanical hyperalgesia that resolved by 72 hr. However, for up to 3 weeks after carrageenan, injection of the inflammatory mediators prostaglandin E2 or 5-hydroxytryptamine or of an adenosine A2agonist into the same site induced a markedly prolonged hyperalgesia (>24 hr compared with 5 hr or less in control rats not pretreated with carrageenan). A nonselective inhibitor of several PKC isozymes and a selective PKCε inhibitor antagonized this prolonged hyperalgesic response equally. Acute carrageenan hyperalgesia could be inhibited by PKA or PKG antagonists. However, these antagonists did not inhibit development of the hypersensitivity to inflammatory mediators. Our findings indicate that different second messenger pathways underlie acute and prolonged inflammatory pain.
Soc Neuroscience